Wuxi Biologics, HRnet IPOs in high demand
Investors threw their weight behind two IPOs in Asia this week, with WuXi Biologics set to price at the top of expectations in Hong Kong and Singapore’s HRnetGroup getting covered across the range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: